Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis.
John D
JD
Lloyd-Still
D003550:Cystic Fibrosis / Q000178:diet therapy*; D004041:Dietary Fats / Q000378:metabolism / Q000627:therapeutic use*; D019587:Dietary Supplements; D004224:Diterpenes; D015777:Eicosanoids / Q000097:blood; D002149:Energy Intake / Q000187:drug effects; D005228:Fatty Acids, Essential / Q000172:deficiency*; D005541:Forced Expiratory Volume / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007408:Intestinal Absorption / Q000502:physiology; D008315:Malondialdehyde / Q000097:blood; D012177:Retinol-Binding Proteins / Q000378:metabolism; D000084562:Retinyl Esters; D014280:Triglycerides / Q000097:blood; D014801:Vitamin A / Q000031:analogs & derivatives / Q000097:blood; D014815:Vitamins / Q000097:blood; D019207:beta Carotene / Q000097:blood
D004041:Dietary Fats; D004224:Diterpenes; D015777:Eicosanoids; D005228:Fatty Acids, Essential; D012177:Retinol-Binding Proteins; D000084562:Retinyl Esters; D014280:Triglycerides; D014815:Vitamins; D019207:beta Carotene; D014801:Vitamin A; C014794:retinol palmitate; D008315:Malondialdehyde